Open Access

Exercise induced hemoconcentration following spleen contraction in subjects with COPD

  • Erika Schagatay1, 2,
  • Anna Hubinette1,
  • Angelica Lodin-Sundström1, 2,
  • Harald Engan1, 2, 3Email author and
  • Nikolai Stenfors4
COPD Research and Practice20151:13

https://doi.org/10.1186/s40749-015-0015-9

Received: 23 August 2015

Accepted: 8 December 2015

Published: 29 December 2015

Abstract

Background

The blood-boosting spleen contraction represents a potential protective response to hypoxia by raising the blood gas storage capacity. Human spleen contraction has been observed during exercise, apnea and simulated altitude resulting in ejection of stored red blood cells into circulation. High-altitude exposure has been shown to increase spleen contraction suggesting that long-term hypoxia may improve the response in humans. Subjects with COPD are often exposed to hypoxia, which limits their physical performance. However, it is not known if spleen contraction occurs in subjects with COPD. Our aim was to reveal whether subjects with COPD recruit the spleen erythrocyte reserve during mild exercise.

Methods

SpO2, spleen volume and Hb were measured before and after 6 min walking test (6MWT) in 24 subjects with COPD. Results were analyzed for all subjects pooled and for subject groups with resting SpO2 above and below 90 % separated and expressed as mean.

Results

6MWT reduced SpO2 from 91 to 83 % and spleen volume from 254 to 181 mL, while Hb increased from 150 to 154 g/L (p = 0.001 for all). Compared to subjects with SpO2 > 90 %, the group with SpO2 < 90 % displayed the largest resting spleen volume (339 vs 202 mL; p = 0.001) and the most pronounced spleen volume reduction (139 vs 40 mL; p = 0.007).

Conclusion

Exercise with hypoxia evokes spleen contraction in subjects with COPD and may represent a protective response during periods of hypoxia. The larger spleen volume and more pronounced contraction in the most hypoxic subjects may suggest long-term adaptation to hypoxia.

Keywords

Hypoxia Erythrocyte reservoir Hemoglobin Physiological stress Protective

Background

The mammalian spleen functions as an erythrocyte reservoir recruited via spleen contraction during physiological stress [1]. In e.g. diving seals, spleen contraction may prolong aerobic dive duration [2, 3]. In healthy human subjects, spleen contraction and circulating hemoglobin (Hb) increase have also been observed during apnea [47]. Interestingly, apnea in splenectomized subjects was found not to induce a Hb increase [5], and neonates with asplenia showed impaired transient elevation of blood Hb in response to acute hypoxia [8]. Bakovic and associates concluded that the contraction is an active process, as no differences in blood flow in the splenic artery or vein occurred [9], and total plasma protein levels remained unchanged across apnea series ruling out extravasation of plasma [5].

Spleen-contraction-induced increases in Hb concentration may have beneficial effects during hypoxia, e.g. prolonging apnea duration [4]. Splenic contribution of Hb to the circulating blood volume has also been observed in healthy subjects during exercise [1012] and more recently during altitude simulation by normobaric hypoxia [13, 14]. This suggests that spleen contraction may be an emergency response triggered in a number of circumstances involving hypoxia. Both hypoxia and hypercapnia will enhance spleen contraction during apnea, with the net effect being greatest with both stimuli present [1315]. Injection of catecholamines has also been shown to induce spleen contraction, suggesting that it is also a general stress response [16, 17].

In competitive apnea divers, it has been noted that the best divers have the largest spleens involving volumes of up to 500 mL and ejection of 250 mL of blood [18] with a hematocrit of about twice normal arterial hematocrit into circulation during apnea [19]. Large spleen volume and the ability to contract the spleen in apneic divers frequently exposed to hypoxia may reflect either inherent predisposition, or possibly a training effect. Both the elevated oxygen (O2) storage and carbon dioxide (CO2) buffering capacity associated with the enhanced hematocrit would be beneficial for prolonging apneic duration by delaying asphyxia.

The ability to withstand acute and chronic hypoxemia is important in several medical conditions, such as respiratory disorders. Subjects with chronic obstructive pulmonary disease (COPD) may have acute, intermittent and/or chronic hypoxemia [20], which limits their physical performance [21]. In subjects with COPD, a dynamic spleen reservoir increasing circulating erythrocyte volume and blood O2 storage capacity would likely be beneficial e.g. during transient periods of physiological strain and also to reduce blood viscosity by filtration of erythrocytes back into the spleen after its re-expansion during periods of rest. It is unknown, however, whether spleen contraction occurs in subjects with COPD, to what degree and under what circumstances. Our aim was to reveal whether subjects with COPD recruit the spleen erythrocyte reserve during mild exercise, and whether spleen volume varies with the level of hypoxia during exercise.

Methods

Subjects

The study was carried out at the Department of Respiratory Medicine at Östersund Hospital, Sweden. The ambition was to include a convenient sample representing subjects with moderate to very severe COPD with patients acting as their own controls, and with a possibility to compare responses between subjects with different levels of O2 saturation. Twenty-four subjects, 9 men and 15 women with moderate to very severe COPD [20], were recruited in connection with an elective outpatient visit. A description of study subjects is presented in Table 1. All subjects had taken their bronchodilators (short-acting β-agonist, long-acting β-agonist, ipatropium, and/or tiotropium) at least one hour prior to the start of the study protocol. Eight subjects had taken their morning beta-blockers prior to the protocol. Four subjects were on long-term O2 therapy 16–20 h/day and arrived to the outpatient department without their O2 therapy, and did not receive O2 therapy during the study measurements. Twenty-one subjects were ex-smokers, two current smokers and one subject had never smoked regularly.
Table 1

Description of the 24 subjects

 

All (N = 24)

Hypoxic (N = 9)

Non-hypoxic (N = 15)

p-value

Male (N)

9

2

7

 

Age (years)

71 (8.8)

72 (8.2)

71 (9.0)

0.758

Height (cm)

166 (8.6)

161 (8.7)

168 (7.4)

0.034

Weight (kg)

69 (14.6)

75 (14.3)

66 (14.1)

0.145

BMI (kg/m2)

25 (5.5)

29 (5.7)

23 (4.1)

0.008

FEV1(Liters)

0.85 (0.32)

0.94 (0.31)

0.8 (0.32)

0.308

FEV1 (% of predicted)

33 (11.7)

39 (12.2)

30 (10.3))

0.053

FVC (Liters)

1.7 (0.5)

1.9 (0.6)

1.7 (0.4)

0.481

FVC (% of predicted)

52 (14.8)

60 (17.6)

47 (10.4)

0.026

FEV1/FVC

0.49 (0.1)

0.52 (0.1)

0.47 (0.1)

0.290

PaO2 (kPa)

8.8 (1.5)

7.4 (0.8)

9.5 (1.2)

0.001

PaCO2(kPa)

5.4 (0.6)

5.6 (0.5)

5.2 (0.6)

0.034

6-min walking test (meters)

297 (95)

267 (87)

314 (98)

0.237

LTOT (N)

4

3

1

 

LAMA (N)

14

6

8

 

ICS (N)

19

7

12

 

SAMA (N)

6

4

2

 

SABA (N)

9

3

6

 

Hypertension (N)

7

4

3

 

Coronary heart disease (N)

6

3

3

 

Diabetes (N)

4

2

2

 

Claudicatio intermittens (N)

2

1

1

 

Current smoker (N)

2

2

  

Former smoker (N)

22

7

15

 

Table text: Data presented as mean (SD). Lung function volumes are post-bronchodilation values. BMI body mass index, FEV forced expiratory volume, FVC forced vital capacity, PaO 2 partial pressure of arterial oxygen, PaO 2 partial pressure of arterial carbon dioxide, LTOT long-term oxygen therapy, LAMA long-acting muscarinic antagonist, ICS inhaled corticosteroid, LABA long-acting beta2-agonist, SAMA short-acting muscarinic antagonist, SABA short-acting beta2-agonist, N number of subjects

Common co-morbidities were hypertension (seven subjects), coronary heart disease (six), and diabetes (four). One subject had alpha-one-antitrypsin deficiency and one had known pulmonary hypertension. Written informed consent was obtained, and the study had been approved by the regional ethics committee at Umeå University, Sweden.

Protocol

The work test protocol consisted of 10 min of sitting rest, followed by the subject standing up for two min and a six min walking test (6MWT) [22] and an additional 10 min of sitting rest. The 6MWT is commonly used in clinical practice and clinical trials of lung disease. The 6MWT was done by walking back and forth on a marked 30 m track at a speed chosen by the subject, after the instruction to try to cover as much distance as possible in 6 min. The subject was accompanied by an assistant walking at arm’s length for safety.

Measurements

On the arrival at the Respiratory Department spirometry was done to measure forced FEV1 (forced expiratory volume first second) and FVC (forced expiratory volume). Heart rate (HR) and peripheral oxygen saturation (SpO2) were measured continuously across the protocol, using a portable pulse-oxymeter (Wristox Nonin 9500 Onyx, Nonin Medical Inc., MN, USA). During the resting periods before and directly after the 6MWT, spleen maximal length (L) thickness (T) and width (W) were measured using ultrasonic imaging (Mindray DP-6600, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China) every minute for volume calculations using the formula Lπ(WT-T2)/3 [7] . The formula is based on the average shape of the spleen, and describes the difference between two ellipsoids divided by two. Capillary blood samples were drawn from the finger after the initial 10 min. rest, directly after 6MWT and 10 min post walking for Hb, which were directly analyzed in triplicate (Hemocue Hb 201+, Hemocue AB, Ängelholm, Sweden) and mean values used.

Analysis

As no gender effects were found, genders were pooled. Analysis of all variables was done for the whole group of 24 subjects, and also for subjects separated into “non-hypoxic” (resting SpO2 > 90 %; n = 15; 7 males) and “hypoxic” (resting SpO2 < 90 %; n = 9; 2 males) COPD groups. Normality of distribution was checked with Shapiro-Wilks test and normal probability plots. As some variables were not normally distributed, non-parametric tests were used in all analyses. Two-sided paired Wilcoxon test with Bonferroni correction for multiple corrections was used to compare the baseline versus post 6MWT values. The individual values of spleen volume, Hb and SpO2 were analyzed for correlation both pre and post 6MWT with Spearman's rank correlation coefficient. Pre values for spleen volume was determined from the last minute before the apnea onset. Mann-Whitney U test was used for comparisons between groups. Significance was accepted at p < 0.05.

Results

Baseline SpO2 correlated to spleen volume (r = −0.55, p = 0.005) and SpO2 post exercise to spleen volume reduction (r = −0.62, p = 0.001).

Spleen volume was reduced along with SpO2 by the 6MWT (p < 0.001; Fig. 1) and changes were reversed within 10 min after the test. Hb was 150 g/L at baseline and had increased by 3.9 g/L after walking (p = 0.001) and after 10 min recovery Hb remained elevated by 1.4 g/L (p = 0.002; Fig. 2). Baseline spleen volume and Hb were correlated to baseline SpO2 (r = −0.55, p = 0.005 and r = −0.50, p = 0.013, respectively). Spleen volume reduction by the 6MWT was correlated to spleen volume at baseline (r = 0.69; p = 0.001) and SpO2 post 6MWT (r = −0.62, p = 0.001), but not to the reduction in SpO2 across the test (r = 0.30; NS) or to the Hb increase (r = −0.19; NS). The degree of desaturation (∆ SpO2) during 6MWD was not correlated with the changes of spleen volume (r = 0.338; NS) or Hb (r = −0.32; NS) from baseline.
Fig. 1

Mean SpO2 and spleen volume (IQR) before and after the 6 min walking test (6MWT) in 24 subjects with COPD. P < 0.001 is indicated with * for SpO2 and P < 0.01 with + for spleen volume compared with pre-walking baseline values

Fig. 2

Mean (IQR) hemoglobin concentration (Hb) after 10 min rest, after 6 min walking and after 10 min recovery in 24 subjects. P < 0.001 is indicated with *** and P < 0.01 with ** compared with values obtained after 10 min rest

During the walking test, mean (SD) heart rate increased from 81 (16) to 105 (19) beats per minute (p = 0.001) and after 10 min recovery it was still slightly elevated at 83 (16) beats per minute (p = 0.009). The subjects covered 297 (95) meters in the 6MWT.

When “hypoxic” (n = 9) and “non-hypoxic” (n = 15) groups were compared, the “hypoxic” group displayed the largest mean resting spleen volume, 339 mL, versus 202 mL in the “non-hypoxic” group (p = 0.001; Fig. 3). The “hypoxic” group also had higher mean Hb concentration than the “non-hypoxic” group at 160 g/L and 144 g/L, respectively (p = 0.003). They also responded to walking with a more pronounced spleen volume reduction, by 139 mL (36 %), compared to subjects with “non-hypoxic” COPD, which displayed a mean reduction of 40 mL (19 %; p = 0.007; Fig. 3). The reduction in SpO2 was of the same magnitude; 9.7 % in “hypoxic” and 9.4 % in “non-hypoxic” subjects (NS). After walking, the “hypoxic” COPD group had a mean Hb increase of 4.5 g/L, compared to 3.5 g/L for the “non-hypoxic” group (NS).
Fig. 3

Mean (IQR) hemoglobin concentration (Hb) and spleen volume after 10 min rest and immediately after 6 min walking (6MWT) in hypoxic subjects (baseline SpO2 < 90 %) and non-hypoxic subjects (baseline SpO2 > 90 %). *** indicates P < 0.001for Hb values and † P < 0.01 for spleen volume values

There was no difference in the distance covered in the 6MWT between “hypoxic” and “non-hypoxic” and COPD groups (267 m versus 314 m; NS). HR responses were also similar in both groups (NS).

Discussion

The principal original findings of this study were that exercise evokes spleen contraction and Hb increase in subjects with COPD, and that the spleen response is enhanced in hypoxic subjects with COPD. The latter finding suggests that this spleen function may be essential for these individuals during hypoxic challenges similar to that found in healthy subjects during maximal exercise [23], high altitude simulation [13, 14] or apnea [4, 5, 7]. In apneic diving, these responses have been shown to be protective against acute hypoxia [5, 18], and we suggest this may be the case also in COPD.

The correlation between spleen volume reduction and the hypoxic load of the disease is in line with observations in high altitude climbers, which were found to have enhanced spleen and Hb responses after a 2 month expedition to Mt Everest [24]. These results suggest that the spleen’s ability to transfuse stored red blood cells into circulation may increase by training or long-term hypoxic exposure.

Subjects with SpO2 > 90 % (“non-hypoxic” group) had spleen volumes in the same range as previously reported for the healthy population [25], while their spleen volume was about 30 % larger in the subjects with SpO2 < 90 % (hypoxic group); in the range of that observed in trained apnea divers [18]. This may suggest that baseline spleen volume could be increased by long-term exposure to chronic hypoxia. However, no increase in spleen volume was observed after the 2 month high altitude expedition [24] although it was previously observed that the best competition freedivers had larger spleens than less successful ones, which could suggest the spleen increases in size when frequently stimulated to contract [26]. In the “hypoxic” subjects with a larger spleen, baseline Hb was also higher than in the “non-hypoxic” group, possibly suggesting that the increased spleen volume may be a response to polycythemia. However, the high altitude climbers had not increased their baseline spleen volumes despite profound polycythemia as a result of the 2 month climb [24], thus any such changes would possibly occur on longer term exposure.

The 36 % spleen contraction seen in the “hypoxic” group was of twice the magnitude compared to the 19 % in the group with the “non-hypoxic” group. A 16 % spleen volume reduction was previously reported in healthy subjects during normobaric hypoxia, but a 34 % reduction was observed in the same subjects during maximal voluntary apnea at rest [14], despite a similar fall in SpO2 of approximately 10 % in the two conditions. A similar fall in SpO2 was present in subjects with COPD, but a fall from a lower initial SpO2 level in the “hypoxic” group could possibly cause a stronger hypoxic stimulus causing the more pronounced contraction. Due to greater baseline spleen volume in the “hypoxic” group, the actual volume expelled differed more from baseline, with a mean 139 mL volume reduction compared to the “non-hypoxic” group, which displayed a mean volume reduction of 40 mL. Thus in the “hypoxic” group, the extra red cell volume was likely 3 times greater, which was also reflected by a greater increase in Hb.

The “hypoxic” group responded with a spleen volume reduction of 139 ml, which is in the range previously found in trained divers [18], and found to have a significant physiological effect [5, 18]. Considering that the spleen contains blood with about twice the Hb as normal blood, the release of red cells would be equivalent to approximately 200 mL of blood, increasing the O2 carrying capacity by ̴ 4 %. This is also supported by the observed elevation of Hb by ̴ 4 %. Such an increase in O2 carrying capacity is likely to have a significant effect on O2 delivery to the tissues in subjects with chronic hypoxia due to lung disease – similar to as during high altitude exposure.

Hypoxia has been shown to be an important trigger of spleen contraction, although not the only factor involved [14, 27]. The magnitude of spleen contraction in the present study was correlated to the degree of exercise-induced and aggravated hypoxia. It is uncertain why the magnitude of spleen contraction was not correlated to the degree of desaturation (∆ SpO2) during 6MWD. One reason could be that the COPD patients were slightly hypoxic at rest, possibly reducing the impact of chemoreception on spleen contraction during exercise. It should be mentioned that the larger degree of spleen contraction previously seen after maximal apnea compared to eupneic hypoxia may reflect an additional influence of hypercapnia [14, 15].

The mean Hb increase of 3.9 g/L after exercise/6MWT in the present study was similar in magnitude compared to previous observations in healthy subjects during apnea [5, 7, 27], exercise [12] and eupneic hypoxia [13]. This response was more pronounced in COPD subjects with a larger spleen suggesting that spleen volume has an impact on the ability to expel erythrocytes. The Hb-response was also enhanced in subjects with pronounced SpO2 reduction after exercise, suggesting that splenic contraction with erythrocyte expulsion is closely related to the degree of hypoxia, in accordance with the study of Richardson et al.,2009 [27]. We suggest that spleen contraction with erythrocyte expulsion may attenuate hypoxia during exercise in subjects with COPD, similar to the effect found during apnea [5, 7]. An important question is whether the responses observed in the present study will be modified by repeated or prolonged exercise, or by long-term hypoxia.

The 6MWT represents a common exercise test in COPD. It reflects maximal exercise capacity, as subjects are asked to walk as far as possible during the 6 min walk, whilst they are able to regulate the intensity throughout the test. Whether an exercise-induced spleen response is observed at lower levels of intensity or shorter duration remains to be seen.

Spleen contraction may temporarily contribute to the high Hb associated with secondary polycytemia, a common condition in COPD [28], which may have harmful consequences related to hyperviscosity and raised pulmonary arterial pressure [29]. Spleen contraction may be involved in exacerbation of shear stress imposed by atherosclerotic plaques and plaque ruptures by increasing blood viscosity during physiological and psychological stress [30, 31], and clearly more research is needed to elucidated the spleen’s role in regulation of stress related hemoconcentration.

The observation that COPD subjects with low baseline SpO2 had a larger spleen could possibly suggest that intermittent or chronic hypoxia may by a “training effect” lead to spleen enlargement, corresponding to observations of large spleens in the best apneic divers [18]. It could, however, also possibly be a consequence of venous pooling to the abdominal organs due to concurrent pulmonary hypertension and right ventricular heart failure, prevalent in many subjects with very severe COPD [32]. A contributing effect of such underlying conditions, although not evident in the patient group studied, cannot be completely ruled out and should be investigated.

As subjects with COPD may have frequent episodes of hypoxemia and thus erythropoietic stress, an enlargement could possibly also be a consequence of extramedullary erythropoesis, or related to hyperplasia of the reticuloendothelial system due to increased destruction of defective erythrocytes [33]. An alternative, and in our view more likely, interpretation of the role of the spleen in this context is that it may protect subjects with COPD and secondary polycytemia against negative consequences related to hyperviscosity, via the splenic erythrocyte storage of excessive red blood cells from circulation during rest. Yet another tentative explanation could be that subjects with COPD with inherently larger spleens sustain the disease better and live longer, and thus are overrepresented in the severe stages of the disease. This observation deserves additional studies in larger materials over time to be fully understood. Since the elevation of Hb increases O2 carrying capacity while also involves an increase in blood viscosity which may lead to increased cardiovascular stress, further research will need to clarify whether the consequences are beneficial or possibly harmful for subjects with COPD. Further studies are also needed to understand the etiology of this response.

The study has some limitations. First, the study population was small and lacked a control group. Furthermore, the study population consisted of a heterogeneous group of subjects with COPD with variations in lung function, medications, spleen volume, Hb, and O2 saturation. Due to the small sample size, only bivariate associations were analyzed. The present studies need confirmation by larger studies with control subjects. The present study population tended to have polycythemia, which is traditionally associated with hypoxia in COPD [34]. It should therefore be investigated in larger studies whether baseline Hb is an independent predictor of the spleen response.

Conclusions

The present study shows that exercise evokes acute, transient spleen contraction and Hb increase in subjects with moderate to very severe COPD and that spleen volume is correlated to the arterial oxygenation. These responses are similar to observations in healthy subjects during maximal exercise or voluntary apnea and may serve as a protection against acute and aggravated hypoxia [5, 18]. The increased spleen volume in COPD subjects with severe hypoxia at rest could be due to long-term adaptation to hypoxia. The stronger response in subjects with baselien SpO2 > 90 % may suggest an upgraded protective response against hypoxia, similar to the enhanced response found in apnea divers.

Abbreviation

Hb: 

hemoglobin concentration

COPD: 

chronic obstructive pulmonary disease

SpO2: 

peripheral oxygen saturation

6MWT: 

6 minute walking test

FEV1: 

forced expiratory volume first second (liters)

FVC: 

forced expiratory volume (liters)

min: 

minutes

NS: 

non significant

Declarations

Acknowledgements

We thank the study subjects for their kind participation in this study, and the nurses at the Respiratory Department, Östersund Hospital, for their assistance with measurements. The study was supported by the Swedish National Center for Research in Sports (CIF) and Unit of Research, Education and Development, Östersund Hospital, Region Jämtland Härjedalen.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Health Sciences, Mid Sweden University
(2)
Swedish Winter Sports Research Centre, Mid Sweden University
(3)
LHL-Klinikkene Røros
(4)
Department of Public Health and Clinical Medicine, Unit of Research, Education and Development - Östersund, Umeå University

References

  1. Stewart IB, Warburton DE, Hodges AN, Lyster DM, McKenzie DC. Cardiovascular and splenic responses to exercise in humans. J Appl Physiol. 2003;94(4):1619–26.View ArticlePubMedGoogle Scholar
  2. Qvist J, Hill RD, Schneider RC, Falke KJ, Liggins GC, Guppy M, et al. Hemoglobin concentrations and blood gas tensions of free-diving Weddell seals. J Appl Physiol. 1986;61(4):1560–9.PubMedGoogle Scholar
  3. Hurford WE, Hochachka PW, Schneider RC, Guyton GP, Stanek KS, Zapol DG, et al. Splenic contraction, catecholamine release, and blood volume redistribution during diving in the Weddell seal. J Appl Physiol. 1996;80(1):298–306.PubMedGoogle Scholar
  4. Hurford WE, Hong SK, Park YS, Ahn DW, Shiraki K, Mohri M, et al. Splenic contraction during breath-hold diving in the Korean ama. J Appl Physiol. 1990;69(3):932–6.PubMedGoogle Scholar
  5. Schagatay E, Andersson JP, Hallen M, Palsson B. Selected contribution: role of spleen emptying in prolonging apneas in humans. J Appl Physiol. 2001;90(4):1623–9. discussion 1606.PubMedGoogle Scholar
  6. Espersen K, Frandsen H, Lorentzen T, Kanstrup IL, Christensen NJ. The human spleen as an erythrocyte reservoir in diving-related interventions. J Appl Physiol. 2002;92(5):2071–9.View ArticlePubMedGoogle Scholar
  7. Schagatay E, Haughey H, Reimers J. Speed of spleen volume changes evoked by serial apneas. Eur J Appl Physiol. 2005;93(4):447–52.View ArticlePubMedGoogle Scholar
  8. Oka T, Itoi T, Hamaoka K. Impaired transient elevation of blood hemoglobin in response to acute hypoxia in neonates with asplenia. Pediatr Int. 2007;49(6):898–902.View ArticlePubMedGoogle Scholar
  9. Bakovic D, Valic Z, Eterovic D, Vukovic I, Obad A, Marinovic-Terzic I, et al. Spleen volume and blood flow response to repeated breath-hold apneas. J Appl Physiol. 2003;95(4):1460–6.View ArticlePubMedGoogle Scholar
  10. Sandler MP, Kronenberg MW, Forman MB, Wolfe OH, Clanton JA, Partain CL. Dynamic fluctuations in blood and spleen radioactivity: splenic contraction and relation to clinical radionuclide volume calculations. J Am Coll Cardiol. 1984;3(5):1205–11.View ArticlePubMedGoogle Scholar
  11. Flamm SD, Taki J, Moore R, Lewis SF, Keech F, Maltais F, et al. Redistribution of regional and organ blood volume and effect on cardiac function in relation to upright exercise intensity in healthy human subjects. Circulation. 1990;81(5):1550–9.View ArticlePubMedGoogle Scholar
  12. Laub M, Hvid-Jacobsen K, Hovind P, Kanstrup IL, Christensen NJ, Nielsen SL. Spleen emptying and venous hematocrit in humans during exercise. J Appl Physiol. 1993;74(3):1024–6.PubMedGoogle Scholar
  13. Richardson MX, Lodin A, Reimers J, Schagatay E. Short-term effects of normobaric hypoxia on the human spleen. Eur J Appl Physiol. 2008;104(2):395–9.View ArticlePubMedGoogle Scholar
  14. Lodin-Sundstrom A, Schagatay E. Spleen contraction during 20 min normobaric hypoxia and 2 min apnea in humans. Aviat Space Environ Med. 2010;81(6):545–9.View ArticlePubMedGoogle Scholar
  15. Richardson MX, Engan HK, Lodin-Sundstrom A, Schagatay E. Effect of hypercapnia on spleen-related haemoglobin increase during apnea. Diving Hyperb Med. 2012;42(1):4–9.PubMedGoogle Scholar
  16. Guntheroth WG. In vivo measurement of dimensions of veins with implications regarding control of venous return. IEEE Trans Biomed Eng. 1969;16(4):247–53.View ArticlePubMedGoogle Scholar
  17. Turner AW, Hodgetts VE. The dynamic red cell storage function of the spleen in sheep. I. Relationship to fluctuations of jugular haematocrit. Aust J Exp Biol Med Sci. 1959;37:399–420.View ArticlePubMedGoogle Scholar
  18. Schagatay E, Richardson MX, Lodin-Sundstrom A. Size matters: spleen and lung volumes predict performance in human apneic divers. Front Physiol. 2012;3:173.View ArticlePubMedPubMed CentralGoogle Scholar
  19. MacDonald IC, Schmidt EE, Groom AC. The high splenic hematocrit: a rheological consequence of red cell flow through the reticular meshwork. Microvasc Res. 1991;42(1):60–76.View ArticlePubMedGoogle Scholar
  20. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–55.View ArticlePubMedGoogle Scholar
  21. Antonucci R, Berton E, Huertas A, Laveneziana P, Palange P. Exercise physiology in COPD. Monaldi Arch Chest Dis. 2003;59(2):134–9.PubMedGoogle Scholar
  22. ATS. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.View ArticleGoogle Scholar
  23. Allsop P, Peters AM, Arnot RN, Stuttle AW, Deenmamode M, Gwilliam ME, et al. Intrasplenic blood cell kinetics in man before and after brief maximal exercise. Clin Sci (Lond). 1992;83(1):47–54.View ArticleGoogle Scholar
  24. Engan HK, Lodin-Sundstrom A, Schagatay F, Schagatay E. The effect of climbing Mount Everest on spleen contraction and increase in hemoglobin concentration during breath holding and exercise. High Alt Med Biol. 2014;15(1):52–7.View ArticlePubMedGoogle Scholar
  25. Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol. 1997;7(2):246–8.View ArticlePubMedGoogle Scholar
  26. Schagatay E, Richardson MX, Lodin-Sundstrom A. Size matters: spleen and lung volumes predict performance in human apneic divers. Front Physiol. 2012. doi:https://doi.org/10.3389/fphys.2012.00173.PubMedPubMed CentralGoogle Scholar
  27. Richardson MX, de Bruijn R, Schagatay E. Hypoxia augments apnea-induced increase in hemoglobin concentration and hematocrit. Eur J Appl Physiol. 2009;105(1):63–8.View ArticlePubMedGoogle Scholar
  28. Freedman BJ, Penington DG. Erythrocytosis in Emphysema. Br J Haematol. 1963;9:425–30.View ArticlePubMedGoogle Scholar
  29. Nakamura A, Kasamatsu N, Hashizume I, Shirai T, Hanzawa S, Momiki S, et al. Effects of hemoglobin on pulmonary arterial pressure and pulmonary vascular resistance in patients with chronic emphysema. Respiration. 2000;67(5):502–6.View ArticlePubMedGoogle Scholar
  30. Engan H, Schagatay E. Spleen Contraction and Hemoconcentration“ Regarding the Review ”Hemoconcentration and Hemostasis During Acute Stress: Interacting and Independent Effects” by Austin et al. 2011. Ann Behav Med. 2015;49(4):634–5.View ArticlePubMedGoogle Scholar
  31. Austin AW, Patterson SM, von Kanel R. Stress-hemoconcentration: plasma volume changes or splenic contraction? A Reply to Engan and Schagatay. Ann Behav Med. 2015;49(4):636–7. doi:https://doi.org/10.1007/s12160-015-9708-1.View ArticlePubMedGoogle Scholar
  32. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32(5):1371–85.View ArticlePubMedGoogle Scholar
  33. Tsantes AE, Papadhimitriou SI, Tassiopoulos ST, Bonovas S, Paterakis G, Meletis I, et al. Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease. Respir Med. 2004;98(11):1117–23.View ArticlePubMedGoogle Scholar
  34. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29(5):923–9.View ArticlePubMedGoogle Scholar

Copyright

© Schagatay et al. 2015

Advertisement